Cargando…
Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort
BACKGROUND: The RASopathies are a class of developmental disorders caused by germline mutations in the RAS-mitogen-activated protein kinase (MAPK) pathway. Hypertrophic cardiomyopathy (HCM) has been frequently described in children with RASopathy, but only a minority of patients have received formal...
Autores principales: | Chen, Hao, Li, Xin, Liu, Xiaoliang, Wang, Jian, Zhang, Zhen, Wu, Jinjin, Huang, Meirong, Guo, Ying, Li, Fen, Wang, Xiumin, Fu, Lijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367752/ https://www.ncbi.nlm.nih.gov/pubmed/30732632 http://dx.doi.org/10.1186/s13023-019-1010-z |
Ejemplares similares
-
Pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: the multifaceted consequences of PTPN11 mutations
por: Calcagni, Giulio, et al.
Publicado: (2019) -
Identification of TAZ mutations in pediatric patients with cardiomyopathy by targeted next-generation sequencing in a Chinese cohort
por: Wang, Jian, et al.
Publicado: (2017) -
In Response to: Pediatric Myelodysplastic Syndrome with Germline RRAS Mutation: Expanding the Phenotype of RASopathies
por: van Engelen, Nienke, et al.
Publicado: (2022) -
Management of rasopathies
por: Yoo, Han-Wook
Publicado: (2013) -
Defining RASopathy
por: Rauen, Katherine A.
Publicado: (2022)